The Promise of a B-cell Biologic Therapy for Rheumatoid Arthritis

Armen Hareyan's picture
Advertisement

Treatment of rheumatoid arthritis

Drugs aimed at suppressing inflammation-provoking cytokines - specifically those linked to T-cells - have improved the treatment of rheumatoid arthritis (RA), a chronic, inflammatory autoimmune disease. Still, the frequency of remission achieved by these biologic agents remains below 50 percent. To increase the success rate of biologic therapy for

Advertisement